Global Breast Cancer Liquid Biopsy Markets, 2012-2019 & 2020-2027 – cfDNA, CTCs, EVs, Reference Laboratories, Hospitals & Physician Laboratories – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Breast Cancer Liquid Biopsy – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Breast Cancer Liquid Biopsy Market to Reach $936.3 Million by 2027

Amid the COVID-19 crisis, the global market for Breast Cancer Liquid Biopsy estimated at US$262.6 Million in the year 2020, is projected to reach a revised size of US$936.3 Million by 2027, growing at a CAGR of 19.9% over the analysis period 2020-2027.

Cell-Free DNA (cfDNA), one of the segments analyzed in the report, is projected to record a 20.1% CAGR and reach US$387.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Circulating Tumor Cells (CTCs) segment is readjusted to a revised 22.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $78.3 Million, While China is Forecast to Grow at 19.5% CAGR

The Breast Cancer Liquid Biopsy market in the U.S. is estimated at US$78.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$164.4 Million by the year 2027 trailing a CAGR of 19.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.9% and 16.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.8% CAGR.

Extracellular Vesicles (EVs) Segment to Record 17.5% CAGR

In the global Extracellular Vesicles (EVs) segment, USA, Canada, Japan, China and Europe will drive the 17.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$41.3 Million in the year 2020 will reach a projected size of US$127.2 Million by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$109.2 Million by the year 2027.

Select Competitors (Total 34 Featured):

• Biodesix, Inc.
• Bio-Rad Laboratories
• Cynvenio Biosystems, Inc.
• Fluxion Biosciences, Inc.
• Genomic Health, Inc.
• Guardant Health, Inc.
• Illumina
• Isogen Life Science B.V.
• Menarini Silicon Biosystems
• Myriad Genetics

   

   

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

• World 15-Year Perspective for Cell-Free DNA (cfDNA) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
• World 15-Year Perspective for Circulating Tumor Cells (CTCs) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
• World 15-Year Perspective for Extracellular Vesicles (EVs) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
• World 15-Year Perspective for Other Circulating Biomarkers by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
• World 15-Year Perspective for Reference Laboratories by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
• World 15-Year Perspective for Hospitals & Physician Laboratories by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
• World 15-Year Perspective for Other End-Uses by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 34

For more information about this report visit https://www.researchandmarkets.com/r/csj79u

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900